Agenus
Develops investigational BOT+BAL antibodies for colorectal cancer and selected tumors.
$7.66
After-hours close0.00 (0.00%)
At close$7.66(−1.92%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 34.52%14.38M sharesInsiders 1.27%528.1K sharesOther 64.21%26.74M shares
Shares outstanding 41.64M · Float 37.19M · 89.3% free float
Institutions13F, as of Jun 30, 2026
110 holders · 14.38M shares · 36 new positions · 68 increased · 18 reduced · 15 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 2.56M | 6.16% | +2.02M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 1.68M | 4.02% | +235.9K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 1.43M | 3.43% | +232.5K | Aug 13, 2026 |
| Siren, L.L.C. | 1.06M | 2.56% | 0 | Aug 13, 2026 |
| Geode Capital Management, LLC | 1.04M | 2.49% | +686.6K | Aug 12, 2026 |
| Mackenzie Financial Corp | 714.2K | 1.72% | +714.2Knew | Aug 13, 2026 |
| Goldman Sachs Group Inc | 448.4K | 1.08% | +416.9K | Aug 14, 2026 |
| Marshall Wace, LLP | 439.6K | 1.06% | −248.6K | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| RA Capital Management, L.P. | 9.90% | 4.34M | 13G | Jul 20, 2026 ↗ |
| Invus Public Equities, L.P. | 8.80% | 3.97M | 13G | Jul 17, 2026 ↗ |
| BlackRock, Inc. | 6.00% | 2.51M | 13G | Jul 27, 2026 ↗ |
| Zynext Ventures USA LLC | 5.90% | 2.13M | 13D | Jan 23, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Garo H. Armen | director, officer: See Remarks | 371.1K | 0.89% | Jul 14, 2026 |
| Steven J. O'Day | officer: Chief Medical Officer | 57.1K | 0.14% | Jun 30, 2025 |
| Thomas L. Harrison | director | 47.5K | 0.11% | Jul 7, 2026 |
| Christine M. Klaskin | officer: PFO & PAO | 23.5K | 0.06% | Jun 30, 2025 |
| Jennifer Buell | director | 19.7K | 0.05% | May 6, 2025 |
| Austin Charette | officer: Principal Accounting Officer | 9.1K | 0.02% | Jan 16, 2026 |
3 ten-percent owners hold 1.25M shares by Form 4, outside the officers-and-directors figure above · 24 people have not refiled in the last 18 months (138.4K shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.